TransCode Therapeutics, Inc. RNAZ
1.60 USD +0.03 (+1.91%)
At closeNov 4, 2026, 4:00 PM EST
1.60 0.00 0.00%
After hours · Nov 4, 4:00 PM ET
1.57 Day range 1.72
1.50 52-week range 12.60
- YTD
- -76.57%
- 1 year
- -83.16%
Held by funds
1 US ETFs and mutual funds hold RNAZ · largest positions
| Fund | Value held | Weight in fund |
|---|---|---|
| VXF | 0.00% |
Ownership
Held by insiders 0.01%
Held by institutions 1.99%
Float held by institutions 1.99%
Institutions 11
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Geode Capital Management, LLC | 0.53% | 3,690 | 13.21K | Sep 29, 2024 |
| Private Capital Management LLC | 0.35% | 2,445 | 8.75K | Sep 29, 2024 |
| Sheets Smith Wealth Management | 0.22% | 1,519 | 5.44K | Sep 29, 2024 |
| Jane Street Group, LLC | 0.17% | 1,204 | 4.31K | Sep 29, 2024 |
| Captrust Financial Advisors | 0.07% | 492 | 1.76K | Sep 29, 2024 |
| Morgan Stanley | 0.04% | 303 | 1.08K | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.42% | 2,906 | 10.40K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.17% | 1,180 | 4.22K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.10% | 686 | 2.46K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.00% | 33 | 118 | Oct 30, 2024 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DUDLEY ROBERT MICHAEL | Chief Executive Officer | Purchase | Sep 27, 2023 | 180,262 |
| FITZGERALD THOMAS A | Chief Financial Officer | Purchase | Sep 27, 2023 | 56,318 |